Clinical trials

A "promotora" (health promoter) from CASA, a Hispanic advocacy group, tries to enroll Latinos as volunteers to test a potential COVID-19 vaccine, at a farmers market in Takoma Park, Md., on Sept. 9, 2020. Minority enrollment in studies of two shots has inched up in recent weeks, but even more is needed this fall as additional vaccine testing gets underway over the next two months. (AP Photo/Federica Narancio)
September 18, 2020 - 10:21 am
TAKOMA PARK, Md. (AP) — In front of baskets of tomatoes and peppers, near a sizzling burrito grill, the “promotoras” stop masked shoppers at a busy Latino farmers market: Want to test a COVID-19 vaccine? Aided by Spanish-speaking “health promoters” and Black pastors, a stepped-up effort is underway...
Read More
An army mascot salutes during the annual Independence Day military parade in Mexico City's main square of the capital, the Zócalo, Wednesday, Sept. 16, 2020. Mexico celebrates the anniversary of its independence uprising of 1810. (AP Photo/Marco Ugarte)
September 16, 2020 - 6:39 pm
MEXICO CITY — A Mexico City official says the capital had 20,535 “excess deaths” attributable to COVID-19 between April and August. That is almost double the official death toll of 11,318 reported for the pandemic in Mexico City. The head of the city’s Digital Innovation Agency says there were 30,...
Read More
University of Idaho students wear face masks while playing a game outside of Sigma Nu fraternity during fraternity bid day, the final day of the recruitment process, on Monday, Aug. 17, 2020, in Moscow, Idaho. Sororities and fraternities at the university are taking a variety of precautions to help prevent the spread of the coronavirus. The first day of classes at the University are on Aug. 24. (Geoiff Crimmins/Moscow-Pullman Daily News via AP)
September 12, 2020 - 2:10 pm
JEFFERSON CITY, Mo. — Missouri has topped 100,000 confirmed cases of the coronavirus. The Missouri Department of Health and Senior Services’ coronavirus dashboard cited 1,974 new confirmed cases of COVID-19 on Saturday, bringing the total since the pandemic began to 101,134. The true number is...
Read More
FILE - This Saturday, July 18, 2020 file photo shows a general view of AstraZeneca offices and the corporate logo in Cambridge, England. Oxford University says on Saturday, Sept. 12 trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K. The university said in large trials such as this “it is expected that some participants will become unwell and every case must be carefully evaluated to ensure careful assessment of safety.” (AP Photo/Alastair Grant, file)
September 12, 2020 - 1:07 pm
LONDON (AP) — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K. patient. In a statement, the university...
Read More
A healthcare worker holds a test tube at a drive-thru COVID-19 testing centre set up at a parking area in east Jerusalem neighborhood of Sheikh Jarrah, Thursday, Sept. 10, 2020. Israel this week imposed new restrictions on some 40 cities and towns with worrying outbreaks, which include nighttime curfews, strict limits on public gatherings and the shuttering of schools. The restrictions mostly affect ultra-Orthodox as well as Arab communities, which have also been hit hard in recent weeks. (AP Photo/Ariel Schalit)
September 10, 2020 - 12:59 pm
WASHINGTON — U.S. health officials have started two new studies to test various blood thinners to try to prevent strokes, heart attacks, blood clots and other complications in COVID-19 patients. Doctors increasingly are finding blood clots throughout the bodies of many people who died from COVID-19...
Read More
A health worker takes a nasal swab sample to test for COVID-19 at an urban health centre in Ahmedabad, India, Thursday, Sept. 10, 2020. India's coronavirus cases are now the second-highest in the world and only behind the United States. (AP Photo/Ajit Solanki)
September 10, 2020 - 5:31 am
NEW DELHI (AP) — India reported another record spike of 95,735 new coronavirus infections in the past 24 hours as the virus spreads beyond its major cities. According to the Health Ministry, the number of people known to be infected in India reached 4,465,863 on Thursday. It has the second-highest...
Read More
Dr. Francis Collins, Director of the National Institutes of Health, attends a Senate Health, Education, Labor and Pensions Committee hearing to discuss vaccines and protecting public health during the coronavirus pandemic on Capitol Hill, Wednesday, Sept. 9, 2020, in Washington. (Greg Nash/Pool via AP)
September 09, 2020 - 12:06 pm
WASHINGTON (AP) — The suspension of a huge COVID-19 vaccine study over an illness in a single participant shows there will be “no compromises” on safety in the race to develop the shot, the chief of the National Institutes of Health told Congress on Wednesday. AstraZeneca has put on hold studies of...
Read More
President Donald Trump speaks during a news conference on the North Portico of the White House, Monday, Sept. 7, 2020, in Washington. (AP Photo/Patrick Semansky)
September 08, 2020 - 5:15 pm
WASHINGTON (AP) — The prospect of a vaccine to shield Americans from coronavirus infection emerged as a point of contention in the White House race as President Donald Trump accused Democrats of “disparaging” for political gain a vaccine he repeatedly has said could be available before the election...
Read More
FILE - This July 18, 2020, file photo, shows the AstraZeneca offices in Cambridge, England. AstraZeneca announced Monday, Aug. 31, its vaccine candidate has entered the final testing stage in the U.S. The company said the study will involve up to 30,000 adults from various racial, ethnic and geographic groups. (AP Photo/Alastair Grant, File)
September 08, 2020 - 4:46 pm
Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued Tuesday evening, the company said its “standard review process triggered a...
Read More
In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)
September 04, 2020 - 8:03 am
MOSCOW (AP) — Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable criticism from experts, as the shots had only been tested on several dozen people before being more...
Read More

Pages